Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Winton Group is a global investment management firm that utilizes a scientific, data-driven approach to financial markets. Founded by David Harding, the company applies advanced mathematical and statistical techniques to identify patterns in large datasets, a methodology it also extends to the life sciences through its venture capital arm, Winton Ventures. Winton Ventures specifically invests in early-stage companies that leverage data science to drive innovation in biotechnology, healthcare, and the physical sciences. While not a drug developer itself, the firm is a significant player in the biotech ecosystem as an investor in high-growth genomic and data-centric healthcare companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Winton Capital.